Among adults with newly diagnosed cancer, rates of low-value cancer services persisted throughout the COVID-19 pandemic in areas ranging from peridiagnosis imaging to end-of-life care.
Aaron L. Schwartz, MD, PhD
Advertisement
Articles by Aaron L. Schwartz, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
SYNCHRONIZE-1 Through a Hepatologist's Lens: Liver Fat Reduction, Visceral Fat, and What Comes Next
2
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
3
Beyond GLP-1: The Biological Case for Dual Incretin Therapy in MASH
4
AI Phenotyping Links Cardiovascular, Kidney Disease to Rapid MASH Progression, Higher Costs
5